Opening book details…
About this Medicine article
FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension by Genovese, Mark C. ;Glover, Josephine ;Greenwald, Maria ;Porawska, Wieslawa ;El Khouri, Elias Chalouhi ;Dokoupilova, Eva ;Vargas, Juan Ignacio ;Stanislavchuk, Mykola ;Kellner, Herbert ;Baranova, Elena ;Matsunaga, Nobuhito ;Alten, Rieke is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Genovese, Mark C. ;Glover, Josephine ;Greenwald, Maria ;Porawska, Wieslawa ;El Khouri, Elias Chalouhi ;Dokoupilova, Eva ;Vargas, Juan Ignacio ;Stanislavchuk, Mykola ;Kellner, Herbert ;Baranova, Elena ;Matsunaga, Nobuhito ;Alten, Rieke
- Publisher
- BioMed Central; Springer (Biomed Central Ltd.); Springer Science and Business Media LLC (ISSN 1478-6354)
- Published
- 2019
- Field
- Medicine (Health Sciences)